DEA schedule
Is acamprosate a controlled substance?
Federal schedule for acamprosate from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Acamprosate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and acamprosate is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted acamprosate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 11 prescription listings from 10 labelers, none with a DEA schedule |
| DEA controlled substances list | acamprosate is not on the list |
Acamprosate NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0378-6333 | Acamprosate Calcium | tablet, delayed release | 333 mg/1 | Mylan Pharmaceuticals Inc. | None |
| 0615-8560 | Acamprosate Calcium | tablet, delayed release | 333 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 0615-8660 | Acamprosate Calcium | tablet, delayed release | 333 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 0904-7213 | Acamprosate Calcium | tablet, delayed release | 333 mg/1 | Major Pharmaceuticals | None |
| 60687-121 | Acamprosate Calcium | tablet, delayed release | 333 mg/1 | American Health Packaging | None |
| 68382-569 | acamprosate calcium | tablet, delayed release | 333 mg/1 | Zydus Pharmaceuticals (USA) Inc. | None |
| 68462-435 | Acamprosate Calcium | tablet, delayed release | 333 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 69452-353 | Acamprosate Calcium | tablet, delayed release | 333 mg/1 | Bionpharma Inc., | None |
| 70069-860 | ACAMPROSATE CALCIUM | tablet, delayed release | 333 mg/1 | Somerset Therapeutics, LLC | None |
| 70518-4616 | acamprosate calcium | tablet, delayed release | 333 mg/1 | REMEDYREPACK INC. | None |
| 70771-1057 | acamprosate calcium | tablet, delayed release | 333 mg/1 | Zydus Lifesciences Limited | None |
Questions
Is acamprosate a controlled substance?
No. Acamprosate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and acamprosate is not on the DEA controlled substances list.
Is acamprosate a narcotic?
No. Acamprosate is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.